Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward

Nature Communications

Volumn 6, Issue , 2015, Pages

  Stouffer, Melissa A ^a   Woods, Catherine A ^b   Patel, Jyoti C ^a   Lee, Christian R ^a   Witkovsky, Paul ^a   Bao, Li ^a   Machold, Robert P ^a   Jones, Kymry T ^a   De Vaca, Soledad Cabeza ^a   Reith, Maarten E A ^a   Carr, Kenneth D ^a   Rice, Margaret E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIORAL RESPONSE; BRAIN; DIET; FOOD PREFERENCE; GLUCOSE; NEUROLOGY; OBESITY; PROTEIN; RODENT;

RATTUS;

DOPAMINE; INSULIN; INSULIN RECEPTOR;

ANIMAL; CHOLINERGIC NERVE CELL; FOOD PREFERENCE; HUMAN; INTERNEURON; MALE; METABOLISM; NUCLEUS ACCUMBENS; OBESITY; PSYCHOLOGY; RAT; REWARD; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CHOLINERGIC NEURONS; DOPAMINE; FOOD PREFERENCES; HUMANS; INSULIN; INTERNEURONS; MALE; NUCLEUS ACCUMBENS; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; REWARD; SIGNAL TRANSDUCTION;

EID: 84946060150     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9543     Document Type: Article

References (66)

1. Schulingkamp, R. J., Pagano, T. C., Hung, D. & Raffa, R. B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24, 855-872 (2000
2. Gerozissis, K. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur. J. Pharmacol. 585, 38-49 (2008
3. Vogt, M. C. & Bruning, J. C. CNS insulin signaling in the control of energy homeostasis and glucose metabolism-from embryo to old age. Trends Endocrinol. Metab. 24, 76-84 (2013
4. Havrankova, J., Schmechel, D., Roth, J. & Brownstein, M. Identification of insulin in rat brain. Proc. Natl Acad. Sci. USA 75, 5737-5741 (1978
5. King, G. L. & Johnson, S. Receptor-mediated transport of insulin across endothelial cells. Science 227, 1583-1586 (1985
6. Strubbe, J. H., Porte, Jr D. & Woods, S. C. Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat. Physiol. Behav. 44, 205-208 (1988
7. Banks, W. A. & Kastin, A. J. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19, 883-889 (1998
8. Banks, W. A. The source of cerebral insulin. Eur. J. Pharmacol. 490, 5-12 (2004
9. Nemoto, T. et al. New insights concerning insulin synthesis and its secretion in rat hippocampus and cerebral cortex: amyloid-b1-42-induced reduction of proinsulin level via glycogen synthase kinase-3b. Cell Signal. 26, 253-259 (2014
10. De Souza, C. T. et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199 (2005
11. Anthony, K. et al. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55, 2986-2992 (2006
12. Kelley, A. E. & Berridge, K. C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22, 3306-3311 (2002
13. Koob, G. F. & Volkow, N. D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238 (2010
14. Werther, G. A. et al. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 121, 1562-1570 (1987
15. Figlewicz, D. P., Evans, S. B., Murphy, J., Hoen, M. & Baskin, D. G. Expression of receptors for insulin and leptin in ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 964, 107-115 (2003
16. Daws, L. C. et al. Insulin signaling and addiction. Neuropharmacology 61, 1123-1128 (2011
17. Figlewicz, D. P. & Sipols, A. J. Energy regulatory signals and food reward. Pharmacol. Biochem. Behav. 97, 15-24 (2010
18. Patterson, T. A. et al. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68, 11-20 (1998
19. Carvelli, L. et al. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81, 859-869 (2002
20. Williams, J. M. et al. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol. 5, e274 (2007
21. Zhen, J., Reith, M. E. A. & Carr, K. D. Chronic food restriction and dopamine transporter function in rat striatum. Brain Res. 1082, 98-101 (2006
22. Schoffelmeer, A. N. et al. Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior. J. Neurosci. 31, 1284-1291 (2011
23. Mebel, D. M., Wong, J. C., Dong, Y. J. & Borgland, S. L. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. Eur. J. Neurosci. 36, 2336-2346 (2012
24. Labouebe, G. et al. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat. Neurosci. 16, 300-308 (2013
25. Konner, A. C. et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab. 13, 720-728 (2011
26. Figlewicz, D. P., Bennett, J. L., Aliakbari, S., Zavosh, A. & Sipols, A. J. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-Administration in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R388-R394 (2008
27. Patel, J. C.,Witkovsky, P., Coetzee, W. A. & Rice, M. E. Subsecond regulation of striatal dopamine release by pre-synaptic KATP channels. J. Neurochem. 118, 721-736 (2011
28. Tepper, J. M. & Bolam, J. P. Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol. 14, 685-692 (2004
29. Zhou, F. M., Liang, Y. & Dani, J. A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4, 1224-1229 (2001
30. Rice, M. E. & Cragg, S. J. Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7, 583-584 (2004
31. Zhang, H. & Sulzer, D. Frequency-dependent modulation of dopamine release by nicotine. Nat. Neurosci. 7, 581-582 (2004
32. Patel, J. C., Rossignol, E., Rice, M. E. & Machold, R. P. Opposing regulation of striatal dopamine release and exploratory motor behavior by forebrain and brainstem cholinergic inputs. Nat. Commun. 3, 1172 (2012
33. Threlfell, S. et al. Striatal dopamine release is triggered by synchronous activity in cholinergic interneurons. Neuron 75, 58-64 (2012
34. Cachope, R. et al. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep. 2, 1-9 (2012
35. Jones, I. W., Bolam, J. P. & Wonnacott, S. Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones. J. Comp. Neurol. 439, 235-247 (2001
36. Higley, M. J. et al. Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum. PLoS ONE 6, e19155 (2011
37. Touzani, K., Bodnar, R. & Sclafani, A. Activation of dopamine D1-like receptors in nucleus accumbens is critical for the acquisition, but not the expression, of nutrient-conditioned flavor preferences in rats. Eur. J. Neurosci. 27, 1525-1533 (2008
38. Sclafani, A., Touzani, K. & Bodnar, R. J. Dopamine and learned food preferences. Physiol. Behav. 104, 64-68 (2011
39. Mayer, C. M. & Belsham, D. D. Central insulin signaling is attenuated by longterm insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation. Endocrinology 151, 75-84 (2010
40. Rice, M. E., Patel, J. C. & Cragg, S. J. Dopamine release in the basal ganglia. Neuroscience 198, 112-137 (2011
41. Smith, Y., Surmeier, D. J., Redgrave, P. & Kimura, M. Thalamic contributions to basal ganglia-related behavioral switching and reinforcement. J. Neurosci. 31, 16102-16106 (2011
42. Threlfell, S. et al. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J. Neurosci. 30, 3398-3408 (2010
43. Hoebel, B. G., Avena, N. M. & Rada, P. Accumbens dopamine-Acetylcholine balance in approach and avoidance. Curr. Opin. Pharmacol. 7, 617-627 (2007
44. Pothos, E. N., Creese, I. & Hoebel, B. G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 15, 6640-6650 (1995
45. Geiger, B. M. et al. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 159, 1193-1199 (2009
46. Morris, J. K. et al. Insulin resistance impairs nigrostriatal dopamine function. Exp. Neurol. 231, 171-180 (2011
47. De Araujo, I. E. et al. Food reward in the absence of taste receptor signaling. Neuron 57, 930-941 (2008
48. Stice, E., Spoor, S., Bohon, C. & Small, D. M. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322, 449-452 (2008
49. Wang, G. J. et al. Brain dopamine and obesity. Lancet 357, 354-357 (2001
50. Johnson, P. M. & Kenny, P. J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 13, 635-641 (2010
51. Carr, K. D., Kim, G.-Y. & Cabeza de Vaca, S. Rewarding and locomotoractivating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology (Berl.) 154, 420-428 (2001
52. Levin, B. E. & Keesey, R. E. Defense of differing body weight set points in diet-induced obese and resistant rats. Am. J. Physiol. 274, R412-R419 (1998
53. Patel, J. C. & Rice, M. E. Monitoring axonal and somatodendritic dopamine release using fast-scan cyclic voltammetry in brain slices. Methods Mol. Biol. 96, 243-273 (2013
54. Lee, C. R., Witkovsky, P. & Rice, M. E. Regulation of substantia nigra pars reticulata GABAergic neuron activity by H2O2 via flufenamic acid-sensitive channels and KATP channels. Front. Syst. Neurosci. 5, 14 (2011
55. Chen, B. T., Moran, K. A., Avshalumov, M. V. & Rice, M. E. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca2+ channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96, 645-655 (2006
56. Li, X. et al. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30, 1788-1797 (2010
57. Wu, Q., Reith, M. E. A., Wightman, R. M., Kawagoe, K. T. & Garris, P. A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112, 119-133 (2001
58. Chen, B. T., Avshalumov, M. V. & Rice, M. E. H2O2 is a novel, endogenous modulator of synaptic dopamine release. J. Neurophysiol. 85, 2468-2476 (2001
59. Witkovsky, P., Patel, J. C., Lee, C. R. & Rice, M. E. Immunocytochemical identification of proteins involved in dopamine release from the somatodendritic compartment of nigral dopaminergic neurons. Neuroscience 164, 488-496 (2009
60. Sugimoto, K. et al. Insulin receptor in rat peripheral nerve: its location and alternatively spliced isoforms. Diabetes Metab. Res. Rev. 16, 354-363 (2000
61. Sanchez-Alavez, M. et al. Insulin causes hyperthermia by direct inhibition of warm-sensitive neurons. Diabetes 59, 43-50 (2010
62. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates 6th edn (Academic, 2007
63. Strubbe, J. H. & Mein, C. G. Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiol Behav. 19, 309-313 (1977
64. Paranjape, S. A. et al. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes 59, 1521-1527 (2010
65. Wise, R. A. & Hoffman, D. C. Localization of drug reward mechanisms by intracranial injections. Synapse 10, 247-263 (1992
66. Zhen, J., Maiti, S., Chen, N., Dutta, A. K. & Reith, M. E. A. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and aspartate 68 in the human dopamine transporter. Eur. J. Pharmacol. 506, 17-26 (2004